Results 231 to 240 of about 213,329 (290)

Co-regulation of HIV control and cytomegalovirus pp65-specific IL-1β and TNF-α responses by genetic variants in the MHC region. [PDF]

open access: yesPLoS Pathog
Ruijten SDE   +20 more
europepmc   +1 more source

Age and CMV are not associated with clinical or immunological response to immune checkpoint blockade

open access: yes
Edwards JM   +7 more
europepmc   +1 more source

CMV Retinitis

Optometry and Vision Science, 1995
ABSTRACT Background. Cytomegalovirus (CMV) retinitis is the most common ocular opportunistic infection in patients with AIDS. CMV retinitis is often asymptomatic and usually appears when the patient's CD4 lymphocyte levels fall below 50/mm3.
openaire   +2 more sources

The ABCs of CMV

Advances in Neonatal Care, 2007
Most infants exposed to cytomegalovirus (CMV) in utero will not be symptomatic; however, infants born with symptomatic CMV will have more severe consequences and poorer prognosis than will asymptomatic infants. The timing of infection during pregnancy largely affects the expected outcomes and consequences to the fetus.
openaire   +2 more sources

Late-onset CMV disease following CMV prophylaxis

Irish Journal of Medical Science, 2009
Cytomegalovirus (CMV) is the most common opportunistic infection after solid-organ transplantation, increasing morbidity and mortality. Three months of oral valganciclovir have been shown to provide effective prophylaxis. Late-onset CMV disease, occurring after the discontinuation of prophylaxis, is now increasingly recognised.To investigate the ...
C, Donnelly   +4 more
openaire   +2 more sources

CMV encephalitis during ganciclovir therapy of CMV retinitis

Infection, 1990
An AIDS patient with cytomegalovirus (CMV) retinitis was treated with ganciclovir (10 mg/kg) for four days followed by 5 mg/kg for 69 days. Clinically, CMV retinitis improved during therapy. Two weeks after induction of therapy, the patient became increasingly disoriented, and died 78 days after admission.
T F, Schwarz   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy